Multimodality Theranostics and Molecular Imaging in the Diagnosis and Treatment of Lung Cancer Kirtee Raparia Kelvin Wong Stephen Wong King C. Li Philip T. Cagle Development of image-guided, multimodality diagnostic…
Metastatic Tumors to the Lung Timothy Craig Allen Metastatic tumors to the lungs are the most common lung neoplasm, and the lungs are the recipient of more metastatic neoplasms than…
Correlation of Imaging with Pathology of Lung Cancer Ronald E. Fisher Philip T. Cagle INTRODUCTION Current imaging techniques correlate very well with the pathology for purposes of diagnosis and staging…
Current Imaging Techniques for the Diagnosis and Staging of Lung Cancer Philip T. Cagle Ronald E. Fisher INTRODUCTION Radiology and nuclear medicine play a vital role in the diagnosis, staging,…
Salivary Gland-like Carcinomas Primary salivary gland tumors of the lung are extremely rare, usually slow-growing, low-grade neoplasms that make up only 0.1% to 0.2% of all lung cancers.1 They originate…
Pulmonary Blastoma Sanja Dacic Pulmonary blastoma is a rare biphasic tumor composed of primitive malignant glands resembling well-differentiated fetal adenocarcinoma and immature, embryonic-type sarcomatous stroma.1 PULMONARY BLASTOMA, CYTOLOGY Pulmonary blastomas…
Giant Cell Carcinoma Sanja Dacic Giant cell carcinoma is an extremely rare variant of non-small cell carcinoma composed of bizarre, pleomorphic, very large mononucleated or multinucleated tumor giant cells identical…
Sarcomatoid (Sarcomatous) Carcinoma Sanja Dacic Sarcomatoid carcinomas are rare and make up only 0.3% to 1.3% of all lung malignancies.1 These tumors are defined by 2004 WHO criteria as a…
Update on Classification of Neuroendocrine Carcinomas Mary Beth Beasley Pulmonary neuroendocrine (NE) carcinomas are generally considered to encompass a spectrum of tumors including the low-grade typical carcinoid (TC) (Fig. 12-1),…
Atypical Carcinoid Tumor Mary Beth Beasley Atypical carcinoid tumor (AC) is a rare pulmonary neoplasm. Carcinoid tumors as a whole make up 1% to 2% of all pulmonary malignancies and…
